The weekly litigation news digest is live. Subscribe now

IP Verse

Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4 - EP3056187

The patent EP3056187 was granted to Altergon on Aug 30, 2023. The application was filed on Nov 13, 2012 under application number EP16154717A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3056187

ALTERGON
Application Number
EP16154717A
Filing Date
Nov 13, 2012
Status
Patent Maintained As Amended
Jul 28, 2023
Publication Date
Aug 30, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIESMay 17, 2019WIBBELMANN -

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2010086030
OPPOSITIONEP1291021
OPPOSITIONUS2006183804
OPPOSITIONUS3128920
OPPOSITIONWO2010086030
SEARCHEP1291021
SEARCHUS3128920
SEARCHWO2010086030

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents